DNAM1 blockade did very little in any of our assays, in opposition to previous reports showing DNAM-1 activation of NK cells via interaction with CD112 (Nectin-2) and CD155 (PVR) on myeloid leukemias (52). This evidence concerns the gene CD226 and myeloid leukemia.